Permanent anosmia after topical nasal anaesthesia with lidocaine 4%.

F. Salvinelli,M. Casale,J. Hardy,L. D'Ascanio,F. Agrò

DOI: https://doi.org/10.1093/BJA/AEI616

IF: 11.719

2005-12-01

British Journal of Anaesthesia

Abstract:

What problem does this paper attempt to address?

An Automatic Insulin Infusion System Based on Kalman Filtering Model Predictive Control Technique

Akshaya Kumar Patra,Anuja Nanda

DOI: https://doi.org/10.1115/1.4048370

2020-10-08

Abstract:Abstract During the past few decades, optimal control of blood glucose (BG) concentration with adequate feedback loop has been of ample importance for Type-I diabetes mellitus (TIDM) patients as far as an artificial pancreas realization is concerned. Now-a-days, in addition to the BG control, the design of the micro-insulin dispenser (MID) with a robust control algorithm to regulate the other chronic clinical disorders based on prolonged medications is also quite indispensable. A novel Kalman filtering model predictive controller (KFMPC) has been proposed in this work to solve the aforementioned problem. For designing of the KFMPC, a ninth-order state-space model of the TIDM patient with MID is considered. In this control strategy, the conventional model predictive controller is re-formulated with a state estimator based on the Kalman filtering methodology to improve the control execution. The justification of enhanced control performance of KFMPC is demonstrated by comparative result analysis with other published control techniques. The simulations are carried out through matlab/simulink environment, and the results indicate comparatively better control ability of the suggested algorithm to control the BG level within the normoglycemic range (70–120 mg/dl) as far as accuracy, stability, quick damping, and robustness.

automation & control systems,instruments & instrumentation
Simultaneous model predictive control and moving horizon estimation for blood glucose regulation in Type 1 diabetes

David A. Copp,Ravi Gondhalekar,João P. Hespanha

DOI: https://doi.org/10.1002/oca.2388

2017-12-14

Optimal Control Applications and Methods

Abstract:Summary A new estimation and control approach for the feedback control of an artificial pancreas to treat Type 1 diabetes mellitus is proposed. In particular, we present a new output‐feedback predictive control approach that simultaneously solves the state estimation and control objectives by means of a single min‐max optimization problem. This involves optimizing a cost function with both finite forward and backward horizons with respect to the unknown initial state, unmeasured disturbances and noise, and future control inputs and is similar to simultaneously solving a model predictive control (MPC) problem and a moving horizon estimation (MHE) problem. We incorporate a novel asymmetric output cost to penalize dangerous low blood glucose values more severely than less harmful high blood glucose values. We compare this combined MPC/MHE approach to a control strategy that uses state‐feedback MPC preceded by a Luenberger observer for state estimation. In‐silico results showcase several advantages of this new simultaneous MPC/MHE approach, including fewer hypoglycemic events without increasing the number of hyperglycemic events, faster insulin delivery in response to a meal consumption, and shorter insulin pump suspensions, resulting in smoother blood glucose trajectories.

automation & control systems,operations research & management science,mathematics, applied
Design of reduced multiple model predictive controller for glucose–insulin regulation in type 1 diabetic patients

Pouya Rikhtehgar,Mohammad Haeri

DOI: https://doi.org/10.1177/01423312241286981

IF: 2.146

2024-11-29

Transactions of the Institute of Measurement and Control

Abstract:Transactions of the Institute of Measurement and Control, Ahead of Print. To maintain stable glucose level, diabetic patients should monitor and control their glucose levels several times a day through insulin injections. However, it is important to acknowledge that errors can occur during such a process, which may affect the desired outcomes. The artificial pancreas is designed to overcome such undesirable situations using a closed-loop control approach. The vital impressing challenge to closed-loop control is dealing with the complexity of glucose–insulin model, including model order and nonlinearity. This paper presents a closed-loop reduced multiple model predictive control to address these complexities, aiming to ease the monitoring and controlling glucose level in type 1 diabetic patients. Considering the influence of meal patterns on glucose control, the reduced model predictive control system is capable of effectively maintaining a safe and stable glucose level. Additionally, cost function in model predictive control could be defined to optimize both the insulin dosage and the glucose level, ensuring a well-balanced approach between the two. To assess the effectiveness of the proposed method, simulations using the Hovorka nonlinear glucose–insulin system are conducted in this regard.

automation & control systems,instruments & instrumentation
Model Predictive Control (MPC) of an Artificial Pancreas with Data-Driven Learning of Multi-Step-Ahead Blood Glucose Predictors

Eleonora Maria Aiello,Mehrad Jaloli,Marzia Cescon

2023-07-22

Abstract:We present the design and \textit{in-silico} evaluation of a closed-loop insulin delivery algorithm to treat type 1 diabetes (T1D) consisting in a data-driven multi-step-ahead blood glucose (BG) predictor integrated into a Linear Time-Varying (LTV) Model Predictive Control (MPC) framework. Instead of identifying an open-loop model of the glucoregulatory system from available data, we propose to directly fit the entire BG prediction over a predefined prediction horizon to be used in the MPC, as a nonlinear function of past input-ouput data and an affine function of future insulin control inputs. For the nonlinear part, a Long Short-Term Memory (LSTM) network is proposed, while for the affine component a linear regression model is chosen. To assess benefits and drawbacks when compared to a traditional linear MPC based on an auto-regressive with exogenous (ARX) input model identified from data, we evaluated the proposed LSTM-MPC controller in three simulation scenarios: a nominal case with 3 meals per day, a random meal disturbances case where meals were generated with a recently published meal generator, and a case with 25$\%$ decrease in the insulin sensitivity. Further, in all the scenarios, no feedforward meal bolus was administered. For the more challenging random meal generation scenario, the mean $\pm$ standard deviation percent time in the range 70-180 [mg/dL] was 74.99 $\pm$ 7.09 vs. 54.15 $\pm$ 14.89, the mean $\pm$ standard deviation percent time in the tighter range 70-140 [mg/dL] was 47.78$\pm$8.55 vs. 34.62 $\pm$9.04, while the mean $\pm$ standard deviation percent time in sever hypoglycemia, i.e., $<$ 54 [mg/dl] was 1.00$\pm$3.18 vs. 9.45$\pm$11.71, for our proposed LSTM-MPC controller and the traditional ARX-MPC, respectively. Our approach provided accurate predictions of future glucose concentrations and good closed-loop performances of the overall MPC controller.

Systems and Control,Artificial Intelligence,Machine Learning
A practical approach based on learning-based model predictive control with minimal prior knowledge of patients for artificial pancreas

Min Hyuk Lim,Sungwan Kim

DOI: https://doi.org/10.1016/j.cmpb.2023.107694

Abstract:Background and objectives: Complete identification of the glucose dynamics for a patient generally requires prior clinical procedures and several measurements for the patient. However, these steps may not be always feasible. To address this limitation, we propose a practical approach integrating learning-based model predictive control (MPC), adaptive basal and bolus injections, and suspension with minimal requirements of prior knowledge of the patient. Methods: The glucose dynamic system matrices were periodically updated using only input values, without any pretrained models. The optimal insulin dose was calculated based on a learning-based MPC algorithm. Meal detection and estimation modules were also introduced. The basal and bolus insulin injections were fine-tuned using the performance of glucose control from the previous day. To validate the proposed method, evaluations with 20 virtual patients from a type 1 diabetes metabolic simulator were employed. Results: Time-in-range (TIR) and time-below-range (TBR) were 90.8% (84.1% - 95.6%) and 0.3% (0% - 0.8%), as represented by the median, first (Q1), and third quartiles (Q3), respectively, when meal intakes were fully announced. When one out of three meal intake announcements was missing, TIR and TBR were 85.2% (75.0% - 88.9%) and 0.9% (0.4% - 1.1%), respectively. Conclusions: The proposed approach obviates the need for prior tests from patients and shows effective regulation of blood glucose levels. From the perspective of practical implementation in clinical environments, to deal with minimal prior information of the patient, our study demonstrates how essential clinical knowledge and learning-based modules can be integrated into a control framework for an artificial pancreas.
Insulin infusion rate control using information theoretic–based nonlinear model predictive control for type 1 diabetes patients

Sahar Zadeh Birjandi,Seyed Kamal Hosseini Sani,Naser Pariz

DOI: https://doi.org/10.1177/01423312221119601

IF: 2.146

2022-09-17

Transactions of the Institute of Measurement and Control

Abstract:Transactions of the Institute of Measurement and Control, Ahead of Print. It has been proven that model predictive control (MPC) is an efficient method for closed-loop insulin delivery in clinical studies. This paper aims to design an observer-based fractional-order nonlinear MPC for type 1 diabetes mellitus (T1DM) patients. It is assumed that the proposed model is nonlinear and contains parametric uncertainty. To estimate unknown states, optimal non-fragile H∞ observer is designed for Lipschitz nonlinear fractional-order systems including parametric uncertainty and the existence of input disturbance. The min–max optimization-based robust fractional model predictive control (RFMPC) has been presented in the following for insulin delivery. Since sensor noise of continuous monitoring of interstitial glucose concentration is considered non-Gaussian, the performance of the proposed controller is improved under non-Gaussian measurement noise by selecting a proper cost function based on generalized correntropy, and as a contrast, the performance of the mean square error (MSE)-based controller is simulated. According to the results, not only is the performance of the proposed controller better under non-Gaussian situations but also effectively reaches the set point in the case of disturbance and uncertainty and provides higher control accuracy and robustness compared with the MSE-based MPC.

automation & control systems,instruments & instrumentation
Blood glucose regulation in type 1 diabetic patients: an adaptive parametric compensation control‐based approach

Anirudh Nath,Dipankar Deb,Rajeeb Dey,Sipon Das

DOI: https://doi.org/10.1049/iet-syb.2017.0093

2018-10-01

IET Systems Biology

Abstract:Here, a direct adaptive control strategy with parametric compensation is adopted for an uncertain non-linear model representing blood glucose regulation in type 1 diabetes mellitus patients. The uncertain parameters of the model are updated by appropriate design of adaptation laws using the Lyapunov method. The closed-loop response of the plasma glucose concentration as well as external insulin infusion rate is analysed for a wide range of variation of the model parameters through extensive simulation studies. The result indicates that the proposed adaptive control scheme avoids severe hypoglycaemia and gives satisfactory performance under parametric uncertainty highlighting its ability to address the issue of inter-patient variability.

cell biology,mathematical & computational biology
Blood glucose regulation and control of insulin and glucagon infusion using single model predictive control for type 1 diabetes mellitus

Cifha Crecil Dias,Surekha Kamath,Sudha Vidyasagar

DOI: https://doi.org/10.1049/iet-syb.2019.0101

2020-06-01

IET Systems Biology

Abstract:This study elaborates on the design of artificial pancreas using model predictive control algorithm for a comprehensive physiological model such as the Sorensen model, which regulates the blood glucose and can have a longer control time in normal glycaemic region. The main objective of the proposed algorithm is to eliminate the risk of hyper and hypoglycaemia and have a precise infusion of hormones: insulin and glucagon. A single model predictive controller is developed to control the bihormones, insulin, and glucagon for such a development unmeasured disturbance is considered for a random time. The simulation result for the proposed algorithm performed good regulation lowering the hypoglycaemia risk and maintaining the glucose level within the normal glycaemic range. To validate the performance of the tracking of output and setpoint, average tracking error is used and 4.4 mg/dl results are obtained while compared with standard value (14.3 mg/dl).

cell biology,mathematical & computational biology
Gaussian Process-Based Model Predictive Control of Blood Glucose for Patients with Type 1 Diabetes Mellitus

Lukas Ortmann,Dawei Shi,Eyal Dassau,Francis J. Doyle III,Steffen Leonhardt,Berno J.E. Misgeld

DOI: https://doi.org/10.1109/ASCC.2017.8287323

2021-01-28

Abstract:The insulin sensitivity (IS) of the human body changes with a circadian rhythm. This adds to the time-varying feature of the glucose metabolism process and places challenges on the blood glucose (BG) control of patients with Type 1 Diabetes Mellitus. This paper presents a Model Predictive Controller that takes the periodic IS into account, in order to enhance BG control. The future effect of the IS is predicted using a machine learning technique, namely, a customized Gaussian Process (GP), based on historical training data. The training data for the GP is continuously updated during closed-loop control, which enables the control scheme to learn and adapt to intra-individual and inter-individual changes of the circadian IS rhythm. The necessary state information is provided by an Unscented Kalman Filter. The closed-loop performance of the proposed control scheme is evaluated for different scenarios (including fasting, announced meals and skipped meals) through in silico studies on simulation models of Göttingen Minipigs.

Systems and Control
Automated blood glucose regulation for nonlinear model of type-1 diabetic patient under uncertainties: GWOCS type-2 fuzzy approach

Mohanad Elhoushy,Belal A Zalam,Amged Sayed,Essam Nabil

DOI: https://doi.org/10.1007/s13534-023-00318-3

2023-10-01

Abstract:Regulating blood glucose level (BGL) for type-1 diabetic patient (T1DP) accurately is very important issue, an uncontrolled BGL outside the standard safe range between 70 and 180 mg/dl results in dire consequences for health and can significantly increase the chance of death. So the purpose of this study is to design an optimized controller that infuses appropriate amounts of exogenous insulin into the blood stream of T1DP proportional to the amount of obtained glucose from food. The nonlinear extended Bergman minimal model is used to present glucose-insulin physiological system, an interval type-2 fuzzy logic controller (IT2FLC) is utilized to infuse the proper amount of exogenous insulin. Superiority of IT2FLC in minimizing the effect of uncertainties in the system depends primarily on the best choice of footprint of uncertainty (FOU) of IT2FLC. So a comparison includes four different optimization methods for tuning FOU including hybrid grey wolf optimizer-cuckoo search (GWOCS) and fuzzy logic controller (FLC) method is constructed to select the best controller approach. The effectiveness of the proposed controller was evaluated under six different scenarios of T1DP using Matlab/Simulink platform. A 24-h scenario close to real for 100 virtual T1DPs subjected to parametric uncertainty, uncertain meal disturbance and random initial condition showed that IT2FLC accurately regulate BGL for all T1DPs within the standard safe range. The results indicated that IT2FLC using GWOCS can prevent side effect of treatment with blood-sugar-lowering medication. Also stability analysis for the system indicated that the system operates within the stability region of nonlinear system.
CHoKI-based MPC for blood glucose regulation in Artificial Pancreas

Beatrice Sonzogni,José María Manzano,Marco Polver,Fabio Previdi,Antonio Ferramosca

2024-01-31

Abstract:This work presents a Model Predictive Control (MPC) for the artificial pancreas, which is able to autonomously manage basal insulin injections in type 1 diabetic patients. Specifically, the MPC goal is to maintain the patients' blood glucose level inside the safe range of 70-180 mg/dL, acting on the insulin amount and respecting all the imposed constraints, taking into consideration also the Insulin On Board (IOB), to avoid excess of insulin infusion. MPC uses a model to make predictions of the system behaviour. In this work, due to the complexity of the diabetes disease that complicates the identification of a general physiological model, a data-driven learning method is employed instead. The Componentwise Hölder Kinky Inference (CHoKI) method is adopted, to have a customized controller for each patient. For the data collection phase and also to test the proposed controller, the virtual patients of the FDA-accepted UVA/Padova simulator are exploited. The proposed MPC is also tested on a modified version of the simulator, that takes into consideration also the variability of the insulin sensitivity. The final results are satisfying since the proposed controller reduces the time in hypoglycemia (which is more dangerous) if compared to the outcome obtained with the standard constant basal insulin therapy provided by the simulator, satisfying also the time in range requirements and avoiding long-term hyperglycemia events.

Systems and Control
Design of Robust Evolving Cloud-Based Controller for Type 1 Diabetic Patients Using n-Beats Algorithm

Jeyakumar,Vijay

DOI: https://doi.org/10.1590/1678-4324-2024230857

2024-06-11

Brazilian Archives of Biology and Technology

Abstract:Kalaimani, Subasri Chellamuthu ; Jeyakumar, Vijay ; Designing and analyzing adaptive controllers to control blood glucose levels by giving insulin in the Lehman-Based Diabetic Patient Model (LBDPM) while considering diverse stochastic environments in gaining popularity is challenging task. RECCo, a notable recent innovation that implements the concept of the ANYA fuzzy rule-based system, is an online adaptive type controller that is used in this study for the application of diabetes. The simulation results show that the suggested controller is used in the model to track standard blood glucose values even in the presence of some unexpected external disturbances. The primary concern in the field of type 1 diabetes is achieving higher accuracy using a deep learning algorithm with data obtained from simulated patient models. To achieve better accuracy, validation of the model is performed using the N-BEATS algorithm. By utilizing an online parameter estimation technique, the RPME is integrated to improve the performance of the adaptive model predictive controller. The system identification technique is used to attain a transfer function that is designed further for implementation of the controller. The experimental validation of the proposed N-BEATS algorithm method is compared with other conventional machine learning algorithms. The proposed controller method attains excellent blood glucose set point tracking and the proposed algorithms give accuracy rates of 97.4% and 96% for the data obtained. It outperforms other state-of-the-art methods with an increase in the accuracy percentage compared with other Benchmark Pima Indian Diabetes Datasets (PIDD).

biology
Optimized type-2 fuzzy controller based on IoMT for stabilizing the glucose level in type-1 diabetic patients

Amged Sayed,Belal A Zalam,Mohanad Elhoushy,Essam Nabil

DOI: https://doi.org/10.1038/s41598-023-41522-6

2023-09-04

Abstract:Due to advancements in existing Internet of Medical Things (IoMT) systems and devices, the blood glucose level (BGL) for type-1 diabetic patients (T1DPs) is effectively and continually monitored and controlled by Artificial Pancreas. Because the regulation of BGL is a very complex process, many efforts have been conducted to design a powerful and effective controller for the exogenous insulin infusion system. The main objective of this study is to propose an optimized interval type-2 fuzzy (IT2F) based controller of artificial pancreas for regulation BGL of T1DP based on IoMT. The proposed controller should avoid the risk of hyperglycemia and hypoglycemia situations that T1DP faces during the infusion of exogenous insulin. The main contribution of this work is using meta-heuristic method called grey wolf optimizer (GWO) to tune the footprint of uncertainty for IT2F's membership functions to inject the proper dose of insulin under different conditions. The nonlinear extended Bergman minimal model (EBMM) with uncertainty is used to represent the blood glucose regulation and represent the dynamics of meal disturbance in T1DP. The effectiveness and the performance of the proposed controller are investigated using MATLAB/Simulink platform. Simulation results show that the proposed controller can avoid both severe hypoglycemia and hyperglycemia for nominal parameters of the model, in addition to model under the presence of both parametric uncertainty and uncertain meal disturbance.
Model predictive control of blood glucose in critically ill patients using Gaussian processes

Carl-Friedrich Benner,Nikolai Weber,Steffen Leonhardt,Marian Walter

DOI: https://doi.org/10.1515/auto-2024-0211

2024-05-08

at - Automatisierungstechnik

Abstract:Stress-induced hyperglycemia and high glycemic variability are common in intensive care patients. Several clinical studies show the benefits of tight blood glucose control, including lower mortality. This article presents an algorithm for blood glucose control in the intensive care unit. An Unscented Kalman Filter is developed to estimate the glucose metabolism state and time-varying insulin sensitivity from blood glucose measurements. Gaussian Processes are used to predict future insulin sensitivity changes based on previous measurements. A model predictive controller is designed to estimate optimal insulin infusion based on current state, predicted insulin sensitivity and planned nutrition. The developed control algorithm allows individualized blood glucose control with reduced glycemic variability and reduced risk of hypoglycemia in the intensive care unit.

automation & control systems
Approaches to Modeling Blood Glucose Dynamics In Type 1 Diabetic Patients for Insulin Pump Automation

Kirill V. Pozhar,Elizaveta A. Polyakova,Evgeniia L. Litinskaia,Aliona O. Ponomariova

DOI: https://doi.org/10.1109/elconrus54750.2022.9755551

2022-01-25

Abstract:With subcutaneous pump insulin therapy, due to the high delay in insulin action, it is necessary to predict the glucose dynamics. Model predictive control requires the development of sufficiently accurate mathematical models of blood glucose dynamics. The work considers the existing empirical, neural network-based, physiological-inspired and combined approaches to glucose modeling. We consider in detail the model used in the T1DMS simulator, which is a stiff system of nonlinear differential equations that includes a number of empirical dependencies. It describes the absorption of glucose during food intake, the dynamics of insulin and glucagon, the processes of utilization and general endogenous production of glucose. The paper proposes an approach to the description of glucose regulation processes, which consists in mapping the enzymes involved in catalysis and inhibition of glycolysis, gluconeogenesis, formation and degradation of glycogen, as well as in the application of the Michaelis-Menten equations for their description.
Optimizing blood glucose regulation in type 1 diabetes: A fractional order controller approach

Manikandan Shenbagam,Ganesan Kanagaraj,Jayant Giri,Vincent F. Yu,Hong Qin,Saurav Mallik

DOI: https://doi.org/10.1063/5.0199980

IF: 1.697

2024-04-01

AIP Advances

Abstract:This study presents the design and implementation of a Fractional Order Proportional, Integral, and Derivative (FOPID) controller intended for the regulation of blood glucose levels in individuals with type 1 diabetes mellitus (T1DM). The efficacy of this controller is evaluated through its application to a nonlinear Stolwijk–Hardy model simulating T1DM patients, accounting for a range of physiological conditions. Utilizing a genetic algorithm, the parameters of the FOPID controller are fine-tuned. By conducting a comparative analysis with previously established control algorithms, the performance of the proposed controller is validated, demonstrating its superior performance. The results underscore the significant improvements achieved by the proposed controller in maintaining blood glucose concentrations within safe thresholds, particularly in scenarios involving disruptions due to meals.

materials science, multidisciplinary,nanoscience & nanotechnology,physics, applied
An Online Stochastic Optimization Approach for Insulin Intensification in Type 2 Diabetes with Attention to Pseudo-Hypoglycemia

Mohamad Al Ahdab,Torben Knudsen,Jakob Stoustrup,John Leth

DOI: https://doi.org/10.48550/arXiv.2204.11380

2022-04-24

Systems and Control

Abstract:In this paper, we present a model free approach to calculate long-acting insulin doses for Type 2 Diabetic (T2D) subjects in order to bring their blood glucose (BG) concentration to be within a safe range. The proposed strategy tunes the parameters of a proposed control law by using a zeroth-order online stochastic optimization approach for a defined cost function. The strategy uses gradient estimates obtained by a Recursive Least Square (RLS) scheme in an adaptive moment estimation based approach named AdaBelief. Additionally, we show how the proposed strategy with a feedback rating measurement can accommodate for a phenomena known as relative hypoglycemia or pseudo-hypoglycemia (PHG) in which subjects experience hypoglycemia symptoms depending on how quick their BG concentration is lowered. The performance of the insulin calculation strategy is demonstrated and compared with current insulin calculation strategies using simulations with three different models.
Run-to-Run Tuning of Model Predictive Control for Type 1 Diabetes Subjects: In Silico Trial

Lalo Magni,Marco Forgione,Chiara Toffanin,Chiara Dalla Man,Boris Kovatchev,Giuseppe De Nicolao,Claudio Cobelli

DOI: https://doi.org/10.1177/193229680900300512

2009-09-01

Journal of Diabetes Science and Technology

Abstract:Background: The technological advancements in subcutaneous continuous glucose monitoring and insulin pump delivery systems have paved the way to clinical testing of artificial pancreas devices. The experience derived by clinical trials poses technological challenges to the automatic control expert, the most notable being the large interpatient and intrapatient variability and the inherent uncertainty of patient information. Methods: A new model predictive control (MPC) glucose control system is proposed. The starting point is an MPC algorithm applied in 20 type 1 diabetes mellitus (T1DM) subjects. Three main changes are introduced: individualization of the ARX model used for prediction; synthesis of the MPC law on top of the open-loop basal/bolus therapy; and a run-to-run approach for implementing day-by-day tuning of the algorithm. In order to individualize the ARX model, a sufficiently exciting insulin profile is imposed by splitting the premeal bolus into two smaller boluses (40% and 60%) injected 30 min before and 30 min after the meal. Results: The proposed algorithm was tested on 100 virtual subjects extracted from an in silico T1DM population. The trial simulates 44 consecutive days, during which the patient receives breakfast, lunch, and dinner each day. For 10 days, meals are multiplied by a random variable uniformly distributed in [0.5, 1.5], while insulin delivery is based on nominal meals. Moreover, for 10 days, either a linear increase or decrease of insulin sensitivity (±25% of nominal value) is introduced. Conclusions: The ARX model identification procedure offers an automatic tool for patient model individualization. The run-to-run approach is an effective way to auto-tune the aggressiveness of the closed-loop control law, is robust to meal variation, and is also capable of adapting the regulator to slow parameter variations, e.g., on insulin sensitivity.
Automated Insulin Delivery for Type 1 Diabetes Mellitus Patients using Gaussian Process-based Model Predictive Control

Lukas Ortmann,Dawei Shi,Eyal Dassau,Francis J. Doyle,Berno J. E. Misgeld,Steffen Leonhardt,Francis J. Doyle III,Berno J.E. Misgeld

DOI: https://doi.org/10.48550/arXiv.2101.11887

2021-01-28

Systems and Control

Abstract:The human insulin-glucose metabolism is a time-varying process, which is partly caused by the changing insulin sensitivity of the body. This insulin sensitivity follows a circadian rhythm and its effects should be anticipated by any automated insulin delivery system. This paper presents an extension of our previous work on automated insulin delivery by developing a controller suitable for humans with Type 1 Diabetes Mellitus. Furthermore, we enhance the controller with a new kernel function for the Gaussian Process and deal with noisy measurements, as well as, the noisy training data for the Gaussian Process, arising therefrom. This enables us to move the proposed control algorithm, a combination of Model Predictive Controller and a Gaussian Process, closer towards clinical application. Simulation results on the University of Virginia/Padova FDA-accepted metabolic simulator are presented for a meal schedule with random carbohydrate sizes and random times of carbohydrate uptake to show the performance of the proposed control scheme.

Permanent anosmia after topical nasal anaesthesia with lidocaine 4%.

An Automatic Insulin Infusion System Based on Kalman Filtering Model Predictive Control Technique

Simultaneous model predictive control and moving horizon estimation for blood glucose regulation in Type 1 diabetes

Design of reduced multiple model predictive controller for glucose–insulin regulation in type 1 diabetic patients

Model Predictive Control (MPC) of an Artificial Pancreas with Data-Driven Learning of Multi-Step-Ahead Blood Glucose Predictors

A practical approach based on learning-based model predictive control with minimal prior knowledge of patients for artificial pancreas

Insulin infusion rate control using information theoretic–based nonlinear model predictive control for type 1 diabetes patients

Blood glucose regulation in type 1 diabetic patients: an adaptive parametric compensation control‐based approach

Blood glucose regulation and control of insulin and glucagon infusion using single model predictive control for type 1 diabetes mellitus

Gaussian Process-Based Model Predictive Control of Blood Glucose for Patients with Type 1 Diabetes Mellitus

Automated blood glucose regulation for nonlinear model of type-1 diabetic patient under uncertainties: GWOCS type-2 fuzzy approach

CHoKI-based MPC for blood glucose regulation in Artificial Pancreas

Design of Robust Evolving Cloud-Based Controller for Type 1 Diabetic Patients Using n-Beats Algorithm

Optimized type-2 fuzzy controller based on IoMT for stabilizing the glucose level in type-1 diabetic patients

Model predictive control of blood glucose in critically ill patients using Gaussian processes

Approaches to Modeling Blood Glucose Dynamics In Type 1 Diabetic Patients for Insulin Pump Automation

Optimizing blood glucose regulation in type 1 diabetes: A fractional order controller approach

An Online Stochastic Optimization Approach for Insulin Intensification in Type 2 Diabetes with Attention to Pseudo-Hypoglycemia

Run-to-Run Tuning of Model Predictive Control for Type 1 Diabetes Subjects: In Silico Trial

Automated Insulin Delivery for Type 1 Diabetes Mellitus Patients using Gaussian Process-based Model Predictive Control